Junfeng Huang

Junfeng Huang

Auto-generated profile, based on publicly available information

Junfeng Huang

School of Pharmacy, University of Wisconsin−Madison, Madison, Wisconsin 53705, United States

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2022 in Analytical Chemistry
Verified
Journal Article
Closed access
DWDanqing Wang
Danqing Wang
MMMin Ma
Min Ma
JHJunfeng Huang
Junfeng Huang
TGTing-Jia Gu
Ting-Jia Gu
YCYusi Cui
Yusi Cui
LLLingjun Li
Lingjun Li

8 July 2019 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Open access
YCYusi Cui
Yusi Cui
KYKa Yang
Ka Yang
DTDylan Nicholas Tabang
Dylan Nicholas Tabang
JHJunfeng Huang
Junfeng Huang
WTWeiping Tang
Weiping Tang
LLLingjun Li
Lingjun Li
Simultaneous enrichment of glyco- and phosphopeptides will benefit the studies of biological processes regulated by these posttranslational modifications (PTMs). It will also reveal potential cross...

17 May 2023 in Journal of Proteome Research
Verified
Journal Article
Closed access
DWDanqing Wang
Danqing Wang
JHJunfeng Huang
Junfeng Huang
HZHaoran Zhang
Haoran Zhang
MMMin Ma
Min Ma
MXMeng Xu
Meng Xu
LLLingjun Li
Lingjun Li

9 October 2023 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
DWDanqing Wang
Danqing Wang
JHJunfeng Huang
Junfeng Huang
HZHaoran Zhang
Haoran Zhang
TGTing-Jia Gu
Ting-Jia Gu
LLLingjun Li
Lingjun Li

25 April 2022 in Analytical Chemistry
Verified
Journal Article
Open access
MLMiyang Li
Miyang Li
JHJunfeng Huang
Junfeng Huang
MMMin Ma
Min Ma
XSXudong Shi
Xudong Shi
LLLingjun Li
Lingjun Li
Despite the important roles of protein sialylation in biological processes such as cellular interaction and cancer progression, simple and effective methods for the analysis of intact sialylglycopeptides (SGPs) are still limited. Analyses of low-abundance SGPs typically require efficient enrichment prior to comprehensive liquid chromatography-mass spectrometry (LC-MS)-based analysis. Here, a novel workflow combining mild periodate oxidation, hydrazide chemistry, copper-catalyzed azide/alkyne cycloaddition (CuAAC) click chemistry, and dynamic covalent exchange, has been developed for selective enrichment of SGPs. The intact SGPs could be separated easily from protein tryptic digests and the signature ions were produced during LC-MS/MS for unambiguous identification. The structure of the signature ions and corresponding dynamic covalent exchange was confirmed by using isotopic reagent. Under the optimized condition, over 70% enrichment efficiency of SGPs was achieved on bovine fetuin digests, and the method was successfully applied to complex biological samples, such as a mouse lung tissue extract. The high enrichment efficiency, good reproducibility, and easily adopted procedure without the need to generate specialized materials make this method a promising tool for broad applications in SGPs analysis.

18 March 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
LDLucas dos Santos Dias
Lucas dos Santos Dias
HDHannah E. Dobson
Hannah E. Dobson
BBBrock Kingstad Bakke
Brock Kingstad Bakke
GKGregory C. Kujoth
Gregory C. Kujoth
JHJunfeng Huang
Junfeng Huang
MWMarcel Wüthrich
Marcel Wüthrich
The development of safe subunit vaccines requires adjuvants that augment immunogenicity of non-replicating protein-based antigens. Current vaccines against infectious diseases preferentially induce protective antibodies driven by adjuvants such as alum. However, the contribution of antibody to host defense is limited for certain classes of infectious diseases such as fungi, whereas animal studies and clinical observations implicate cellular immunity as an essential component of the resolution of fungal pathogens. Here, we decipher the structural bases of a newly identified glycoprotein ligand of Dectin-2 with potent adjuvancy, Blastomyces endoglucanase-2 (Bl-Eng2). We also pinpoint the developmental steps of antigen-specific CD4+ and CD8+ T responses augmented by Bl-Eng2 including expansion, differentiation and tissue residency. Dectin-2 ligation led to successful systemic and mucosal vaccination against invasive fungal infection and Influenza A infection, respectively. O-linked glycans on Bl-Eng2 applied at the skin and respiratory mucosa greatly augment vaccine subunit- induced protective immunity against lethal influenza and fungal pulmonary challenge.